Miyaoka Y, Moriyama T, Saito S, Rinno S, Kato M, Tsujimoto R, Suzuki R, China R, Nagai M, Kanno Y. Larger degree of renal function decline in CKD is a favorable factor for the attenuation of eGFR slope worsening by SGLT2 inhibitors: a retrospective observational study. Nephron. 2024
Tatsumoto N, Saito S, Rifkin IR, Bonegio RG, Leal DN, Sen GC, Arditi M, Yamashita M. EGF Receptor-dependent TLR7 Signaling in Macrophages Promotes Glomerular Injury in Crescentic Glomerulonephritis. Laboratory investigation; a journal of technical methods and pathology. 2023
Saito S, Shin-ichiro Ohno, Harada Y, Kanno Y, Kuroda M. MiR-34a induces myofibroblast differentiation from renal fibroblasts. Clinical and experimental nephrology. 2023
Suguru Saito, Toshiyuki Nakao. Semaglutide, a newly available glucagon-like peptide receptor agonist, shows remarkable favorable effects in hemodialysis patients with obesity and Type 2 diabetes. Therapeutic Apheresis and Dialysis. 2022
Angiotensin-converting enzyme in neutrophils ameliorates glomerular damage in immune-complex mediated crescentic glomerulonephritis via complement C3 and C/N domains of ACE
(American Society of Nephrology Kidney Week 2024 2024)
ACE in granulocytes has a protective role in crescentic glomerulonephritis via complement lectin pathway independent of Angiotensin II
(American Society of Nephrology Kidney Week 2023 2023)